Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cohort
AddedFeb 15, 2024
UpdatedJul 22, 2026
Cohort

Cohort

Cohort's software enhances Chronic Care Management, boosting efficiency, outcomes, and clinical trial enrollment.

HQ
New York City, NY, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Cohort, founded with a mission to revolutionize chronic care management, offers advanced software solutions aimed at enhancing the efficiency and outcomes of Chronic Care Management (CCM) programs. Their platform enables Primary Care Providers (PCPs) to scale their CCM efforts and streamline clinical trial identification and enrollment. Cohort focuses on serving patients, health systems, payers, Accountable Care Organizations (ACOs), and physician practices by providing scalable, technology-enhanced services for chronic condition management.

Notable figures affiliated with Cohort include key healthcare professionals and technology experts who drive the company's innovative approach. The company has attracted significant interest from investors focused on health tech advancements. Among its key achievements are improved patient engagement and better health outcomes through consistent, trust-based interactions. Cohort's impact is evident in its ability to extend the reach of clinical care beyond traditional settings, thereby enhancing the overall healthcare ecosystem.

Cohort - Similar Companies

Cohere Health logo

Cohere Health

coherehealth.com

Patient Engagement Systems logo

Patient Engagement Systems

CareHarmony logo

CareHarmony

care-harmony.com

cliexa logo

cliexa

cliexa.com

High Enroll logo

High Enroll

highenroll.org

Citruslabs logo

Citruslabs

citruslabs.com

Cohero Health logo

Cohero Health

Emmacare logo

Emmacare

emmacare.com

CareSkore logo

CareSkore

careskore.com

On-Time Trials logo

On-Time Trials

ontimetrials.com

AiCure logo

AiCure

aicure.com

CareBridge logo

CareBridge

Compwell logo

Compwell

compwellco.com

H3C logo

H3C

h3ci.com

Continual Care Solutions logo

Continual Care Solutions

Cohort - Quick Facts

Who are Cohort's competitors?

Companies similar to Cohort include Cohere Health, Patient Engagement Systems, CareHarmony and cliexa.

When was Cohort founded?

Cohort was founded in 2016.

Where is Cohort's headquarters located?

Cohort's headquarters is located in New York City, NY, US.

When was Cohort's last funding round?

Cohort's most recent funding round was for $11M (USD) in February 2021.

How much has Cohort raised to-date?

As of Feb 15, 2021, Cohort has raised a total of $11M (USD).

How many employees does Cohort have?

Cohort has 30 employees as of Feb 4, 2024.

Cohort - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Usage-based
Customer
  • Enterprise
Main Product
  • Care Management
  • Software
Tags
  • Health Systems
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software